REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF SAN BERNARDINO COUNTY
AND RECORD OF ACTION
June 14, 2022
FROM
TRACY REECE, Chief Probation Officer, Probation Department
SUBJECT
Title
Application and Acceptance of Intranasal Naloxone Hydrochloride from California Department of Health Care Services' Naloxone Distribution Project
End
RECOMMENDATION(S)
Recommendation
1. Approve application for 600 units of intranasal Naloxone Hydrochloride from California Department of Health Care Services.
2. Accept 600 units of intranasal Naloxone Hydrochloride from California Department of Health Care Services.
(Presenter: Tracy Reece, Chief Probation Officer, 387-5692)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Operate in a Fiscally-Responsible and Business-Like Manner.
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of this item will not result in the use of additional Discretionary General Funding (Net County Cost). The Probation Department (Department) will receive the Naloxone Hydrochloride at no cost. The Department will report any successful overdose reversals to California Department of Health Care Services.
BACKGROUND INFORMATION
Naloxone Hydrochloride (Naloxone) is a life-saving medication that reverses an opioid overdose, while having little to no effect in the event it is administered on an individual who does not have opioids in their system. Naloxone works by blocking the opioid receptor sites, reversing the toxic effects of the overdose. Naloxone requires a prescription but is not a controlled substance. It has few known adverse effects, and no potential for abuse.
Naloxone is administered when a patient is showing signs of opioid overdose. The medication can be given by intranasal spray, intramuscular (into the muscle), subcutaneous (under the skin), or by intravenous injection. The Department is applying for 600 units of Naloxone intranasal spray.
The Naloxon...
Click here for full text